Atossa Therapeutics, Inc. (ATOS)
NASDAQ: ATOS · Real-Time Price · USD
0.7380
+0.0746 (11.25%)
Apr 23, 2025, 4:00 PM EDT - Market closed

Atossa Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
951191106720337
Upgrade
Market Cap Growth
7.71%7.71%64.77%-66.97%445.88%158.90%
Upgrade
Enterprise Value
244417-506329
Upgrade
Last Close Price
0.740.940.880.531.600.95
Upgrade
PB Ratio
1.331.661.210.571.471.37
Upgrade
P/TBV Ratio
1.331.661.210.571.471.40
Upgrade
Debt / Equity Ratio
-----0.00
Upgrade
Quick Ratio
14.3114.3116.9020.0543.972.57
Upgrade
Current Ratio
14.9914.9917.6121.2345.182.73
Upgrade
Return on Equity (ROE)
-31.39%-31.39%-28.80%-21.05%-24.93%-88.42%
Upgrade
Return on Assets (ROA)
-19.99%-19.99%-17.84%-13.07%-13.93%-31.85%
Upgrade
Return on Capital (ROIC)
-21.25%-21.25%-18.77%-13.52%-15.52%-45.20%
Upgrade
Earnings Yield
-26.75%-21.47%-27.29%-40.29%-10.17%-48.03%
Upgrade
FCF Yield
-22.08%-17.72%-19.00%-31.06%-8.13%-31.20%
Upgrade
Buyback Yield / Dilution
0.18%0.18%0.43%-8.27%-934.13%-33.09%
Upgrade
Updated Mar 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q